Part 1. The Postpartum Metabolic Puzzle
The birth of a child produces one of the most abrupt physiological transitions in normal human life. During pregnancy, a woman’s metabolism, hormones, immune system, nutritional requirements, and sleep patterns are altered to support both mother and developing child. At delivery, many of these adaptations change rapidly. Within days, the mother must recover from childbirth while often beginning lactation and adapting to interrupted sleep and the demands of caring for a newborn. It is also during this period that some women experience significant disturbances of mood and, much more rarely, severe psychiatric illness.
Postpartum psychiatric illness occurs along a spectrum. Transient emotional disturbance, commonly called the “baby blues,” is frequent. Postpartum depression is considerably more serious, while postpartum psychosis is rare but potentially life-threatening. Postpartum psychosis occurs in approximately one to two women per thousand deliveries and commonly begins within the first weeks following childbirth. Modern research has implicated hormonal changes, immune activity, genetic susceptibility, and disruption of sleep and circadian rhythms, but no single mechanism adequately explains why childbirth acts as such a powerful psychiatric trigger in susceptible women.
One potentially important part of this transition involves tryptophan and vitamin B3 (niacin) metabolism. Tryptophan is an essential amino acid: the human body cannot manufacture it and therefore ultimately depends upon dietary sources. Tryptophan is required for protein synthesis, but it also serves as the starting material for several biologically important pathways. A small proportion can be used in the production of serotonin and melatonin, while a much larger proportion normally enters the kynurenine pathway. This pathway produces several neurologically active compounds and ultimately contributes to the synthesis of nicotinamide adenine dinucleotide, or NAD+, a molecule essential to cellular energy metabolism and numerous other cellular processes.
Pregnancy produces a striking alteration in this system. Research examining hundreds of pregnant women found that urinary metabolites of the tryptophan-niacin pathway increased progressively beginning in mid-pregnancy and reached approximately two to three times nonpregnant levels during late pregnancy. After childbirth, these metabolites declined toward nonpregnant levels. Earlier research likewise found that conversion of tryptophan into niacin metabolites was considerably more efficient during pregnancy than during the postpartum state.
This raises an intriguing question. What happens in a woman whose supply of tryptophan, niacin, or other nutrients involved in these pathways is marginal when the enhanced metabolic state of pregnancy suddenly ends?
The question becomes more significant because postpartum research has independently identified abnormalities involving tryptophan. A systematic review and meta-analysis found that lower total blood tryptophan during the first five days following childbirth was significantly associated with postpartum depression. This does not demonstrate that insufficient dietary tryptophan causes postpartum depression, nor does it establish that tryptophan supplementation would prevent it. It does, however, indicate that tryptophan metabolism is a legitimate biological variable in postpartum mood disorders and deserves further investigation.
These observations invite reconsideration of an older and controversial psychiatric theory. Beginning in the 1950s, Canadian psychiatrist Dr. Abram Hoffer, working closely with Humphry Osmond, proposed that disturbances involving vitamin B3, adrenaline metabolism, oxidative chemistry, and individual biochemical requirements could contribute to schizophrenia and certain psychotic illnesses. Hoffer became particularly associated with the therapeutic use of large doses of niacin or niacinamide. His theories, especially the proposed role of adrenochrome, remained controversial and were never accepted as an established explanation for schizophrenia.
The purpose of this paper is not to assume that Hoffer was correct, nor to propose that postpartum depression is simply a vitamin B3 deficiency. Rather, it asks a narrower question: whether modern knowledge of pregnancy and postpartum metabolism provides sufficient reason to reconsider portions of Hoffer’s biochemical reasoning in this particular physiological setting.
Such an investigation must consider several processes together. Pregnancy substantially increases tryptophan-to-niacin metabolism. That adaptation diminishes following delivery. At the same time, the mother encounters major hormonal changes, physical recovery, possible nutritional depletion, lactation, interrupted sleep, and psychological and physiological stress. Stress itself can influence tryptophan metabolism through the kynurenine pathway, providing another possible connection between the postpartum environment and metabolic vulnerability.
Breastfeeding introduces another participant into this metabolic system: the infant. Mother and child are no longer physiologically joined by the placenta, but they remain nutritionally connected through breast milk. Maternal nutritional status may therefore affect not only the mother but potentially the nutrient supply available to the infant. If maternal nutritional insufficiency contributed to infant irritability or poor sleep—a possibility that would require independent evidence—the resulting increase in crying and maternal sleep disruption could conceivably intensify the mother's stress. This suggests the possibility of a mother-infant feedback loop, although several links in that proposed chain remain hypothetical.
The central hypothesis examined in this paper can therefore be stated cautiously: in a susceptible woman, the abrupt postpartum alteration of tryptophan-niacin metabolism, combined with nutritional demands, lactation, stress, and sleep disruption, might contribute to a biochemical environment favorable to postpartum mood disturbance or psychosis.
Hoffer's work provides one historical framework through which to examine this possibility. Modern research on tryptophan, kynurenine, niacin and NAD+ provides another. Bringing the two together does not establish a treatment. It does, however, produce a series of specific and testable questions about maternal nutrition and postpartum mental health.
The first task is therefore to understand what Hoffer actually proposed, why he believed vitamin B3 could influence serious psychiatric illness, what clinical evidence he offered, and why his conclusions became so controversial.
Part 2. Hoffer and Osmond: Niacin, Adrenaline, and the Adrenochrome Hypothesis
Abram Hoffer's interest in vitamin B3 did not begin with the simple proposition that schizophrenia was caused by a vitamin deficiency. His theory was considerably more ambitious. Hoffer and his colleague Humphry Osmond believed that schizophrenia might, at least in some patients, result from an abnormality in the body's handling of adrenaline and related compounds. Vitamin B3 entered their treatment because they believed it could alter this biochemical process.
Their work developed in Saskatchewan during an unusually fertile period in biological psychiatry. In 1952, Osmond and psychiatrist John Smythies proposed that schizophrenia might involve an abnormal product of adrenaline metabolism. Their reasoning arose partly from comparisons between schizophrenia and the altered mental states produced by mescaline. Mescaline possessed certain chemical similarities to adrenaline, leading them to wonder whether the human body might manufacture an adrenaline-related substance capable of producing comparable disturbances of perception and thought. They initially called this hypothetical compound the "M-substance."
Hoffer soon joined the investigation. Attention eventually centered upon adrenochrome, an oxidation product of adrenaline. Adrenochrome was not an imaginary substance; adrenaline can oxidize to form it. The controversial question was whether adrenochrome was produced in physiologically important amounts within the human body and, more importantly, whether abnormal production or handling of it could contribute to mental illness. Hoffer and Osmond eventually proposed what became known as the adrenochrome hypothesis of schizophrenia.
Stress, Adrenaline, and an Endogenous Toxin
The starting point was adrenaline.
Adrenaline, or epinephrine, is one of the body's principal responses to stress. Fear, danger, excitement, illness, and other physiological stresses can activate systems that increase catecholamine activity. Hoffer and Osmond reasoned that if a psychologically active substance could be produced from adrenaline, then prolonged or excessive stress might increase the raw material from which that substance could be formed.
Their proposed sequence can be simplified:
Stress or physiological disturbance
↓
increased catecholamine activity
↓
adrenaline
↓ oxidation
adrenochrome and related aminochromes
↓
disturbance of brain function in a susceptible person
This was never meant to imply that ordinary stress automatically produced schizophrenia. Everyone produces adrenaline. Hoffer's theory required an additional individual vulnerability—an abnormality in the production, metabolism, oxidation, or detoxification of adrenaline-derived compounds.
The idea therefore attempted to explain an observation familiar to psychiatry: severe psychological or physiological stress can precipitate psychiatric illness in some susceptible individuals while having no such effect in most people.
Hoffer and Osmond proposed that excessive adrenochrome could interfere with brain function in a manner analogous, in broad terms, to hallucinogenic drugs. They and other investigators performed experiments with adrenochrome in animals and humans and reported perceptual and psychological effects. The consistency and interpretation of those experiments subsequently became controversial, and later reviewers did not regard them as establishing adrenochrome as the cause of schizophrenia. Nevertheless, the experiments encouraged Hoffer and Osmond to continue developing their hypothesis.
Importantly, even contemporary descriptions of their theory were somewhat more cautious than the shorthand statement that "adrenochrome causes schizophrenia." A 1950s discussion of the hypothesis noted that Hoffer and his colleagues did not insist that adrenochrome itself had been conclusively identified as the toxic agent. They proposed that adrenochrome or a related adrenaline-derived compound might be involved.
Why Vitamin B3?
The next question was therapeutic. If abnormal adrenaline metabolism contributed to schizophrenia, could that metabolism be changed?
This brought Hoffer to vitamin B3, principally nicotinic acid, or niacin, and later nicotinamide.
Hoffer was interested in niacin partly because of its relationship to cellular metabolism and partly because of its proposed influence upon adrenaline chemistry. Hoffer and Osmond sought compounds that might decrease the production of potentially harmful adrenaline oxidation products without preventing the body from producing the adrenaline it legitimately needed.
They therefore did not view niacin simply as a vitamin being given to correct pellagra. They were using it pharmacologically, in quantities far exceeding ordinary nutritional requirements.
Typical early treatment involved approximately 3 grams of vitamin B3 per day, commonly divided into several doses. This is hundreds of times greater than the amount required merely to prevent dietary niacin deficiency. Hoffer therefore increasingly spoke of certain patients as having unusually large biochemical requirements rather than conventional vitamin deficiencies.
This distinction became central to what would later be called orthomolecular medicine. A person could consume enough of a nutrient to prevent a classical deficiency disease yet, according to Hoffer, still require considerably more of that substance for optimal biochemical functioning or because of an individual metabolic abnormality.
Whether such extraordinarily high individual requirements actually explain schizophrenia remains disputed. But understanding this distinction is essential to understanding Hoffer. His argument was not:
schizophrenic patients have pellagra.
It was closer to:
some schizophrenic patients may possess a biochemical abnormality whose consequences can be modified by unusually large amounts of vitamin B3.
The Clinical Experiments
Hoffer and Osmond did not limit themselves to biochemical speculation. They attempted to test the treatment clinically.
During the 1950s they conducted controlled studies in patients diagnosed with schizophrenia, adding large doses of nicotinic acid or nicotinamide to the psychiatric treatment then available. Their early results persuaded them that vitamin B3 substantially improved outcomes, particularly among patients whose illness was relatively recent.
A later historical review describes Hoffer and Osmond as proposing the adrenochrome hypothesis in 1952 and subsequently reporting an apparently successful double-blind experiment using large doses of niacin.
This distinction between acute and chronic schizophrenia eventually became important.
Hoffer believed patients early in their illness were much easier to treat. Once schizophrenia had persisted for years, he believed treatment became more difficult and could require both substantially higher doses of vitamin B3 and much longer periods of treatment, with the dose adjusted according to the individual patient's response and tolerance. Thus, in Hoffer's view, a relatively short trial using the approximately 3 grams per day employed in his early studies of acute schizophrenia was not necessarily an adequate test of his approach in a patient who had been chronically ill for years. This distinction later became central to his disagreement with researchers who attempted to replicate his work.
It is sometimes therefore said that Hoffer's treatment was intended only for newly diagnosed schizophrenia. That is not quite correct.
Hoffer also treated chronic psychiatric patients and continued to argue that some long-term patients could improve substantially. What changed was his expectation regarding the dose, duration, and probability of recovery. A patient ill for many years could not necessarily be expected to respond to a brief trial of the same fixed dose used in an acutely ill patient.
This would later become one of the central methodological disputes surrounding his work.
Niacin Was Not His Entire Treatment
Another misunderstanding is to reduce Hoffer's approach to the statement:
Give a schizophrenic patient niacin.
His clinical program eventually became considerably broader.
Depending upon the patient and period of his career, Hoffer employed vitamin B3 together with vitamin C, nutritional and dietary changes, other nutrients when indicated, and conventional psychiatric treatments. He did not generally argue that psychiatric medications should simply be abandoned. Rather, he believed nutritional treatment could be combined with them and that medication could sometimes be reduced as patients improved.
This creates an important difficulty when evaluating his claims. A study testing niacin alone may provide a clean test of whether niacin itself has a therapeutic effect, but it does not necessarily reproduce Hoffer's complete clinical program. Conversely, if the treatment consists of numerous individually adjusted interventions, determining which component produced an improvement becomes much more difficult.
That tension would follow orthomolecular psychiatry for decades.
Chronic Patients and the Question of Time
Hoffer's experience with chronic institutionalized patients is particularly relevant.
Some subsequent investigators administered approximately 3 grams of niacin daily to chronic schizophrenic patients for relatively short periods and found little or no significant improvement. Hoffer did not regard these results as demonstrating that vitamin therapy was useless in chronic schizophrenia. He instead argued that long-established illness represented a fundamentally more difficult therapeutic problem.
This distinction matters because the two propositions are not identical:
"Niacin does not help chronic schizophrenia."
and
"A fixed dose of niacin administered for a limited period did not produce measurable improvement in this particular group of chronic patients."
Hoffer accepted the second result while disputing the first conclusion.
His later clinical reports emphasized prolonged treatment and functional recovery: whether patients remained outside the hospital, maintained relationships, worked, and avoided repeated hospitalization. In his view, recovery from a long-standing metabolic and psychiatric disorder might take months or years rather than several weeks.
These observations are clinically interesting, but they also present an obvious scientific problem. Long-term case histories and uncontrolled clinical experience cannot establish causation as reliably as randomized controlled trials. Patients can improve for many reasons, psychiatric illnesses fluctuate naturally, diagnostic criteria change, and patients receiving nutritional treatment frequently receive other treatments simultaneously.
Hoffer's chronic-patient experience therefore constitutes evidence that generated a hypothesis, but it cannot by itself establish the effectiveness of high-dose niacin.
The Replication Controversy
By the late 1960s and early 1970s, larger attempts to reproduce the Saskatchewan results had failed to demonstrate the dramatic benefits Hoffer claimed. Canadian Mental Health Association collaborative studies were particularly influential in turning mainstream psychiatry against megadose niacin treatment. Historical accounts consequently describe Hoffer's favorable results as having failed replication.
Hoffer and his supporters disputed whether these experiments constituted genuine replications.
Their objections generally concerned several factors: the use of heavily chronic rather than newly ill patients; treatment periods they considered too short; standardized doses rather than individually adjusted treatment; differences in diagnostic criteria; and failure to reproduce the larger nutritional and clinical program in which Hoffer used vitamin B3.
There is merit in asking whether a replication actually reproduces the conditions of the original claim. A treatment reported to work best in recently ill patients cannot necessarily be disproved by demonstrating poor results in people institutionalized for many years.
But there is an equally important objection from Hoffer's critics. If every negative trial can be explained by arguing that the patients were too chronic, the dose was incorrect, treatment was too short, or some other component of the program was missing, the hypothesis becomes increasingly difficult to falsify.
That remains one of the fundamental problems in evaluating Hoffer's clinical legacy.
What Became of the Adrenochrome Theory?
Mainstream psychiatry ultimately did not accept the adrenochrome hypothesis as an established explanation for schizophrenia, and high-dose niacin did not become a standard treatment. Later historical analysis has criticized both Hoffer's diagnostic methods and the interpretation of his clinical experiments.
Yet the biochemical question did not disappear quite as completely as is sometimes assumed.
Later researchers continued investigating oxidative products of catecholamines, oxidative stress, free radicals, and their possible neurological effects. A 2003 review, for example, reconsidered evidence concerning the occurrence of adrenochrome in the nervous system and enzymes capable of detoxifying it. This did not validate Hoffer's schizophrenia theory, but it illustrates that the underlying chemistry remained a legitimate subject of investigation.
Hoffer himself eventually broadened his terminology from an exclusively adrenochrome hypothesis toward an aminochrome hypothesis, emphasizing potentially harmful oxidation products of catecholamines more generally.
This distinction is important for the present inquiry.
It is unnecessary to demonstrate that adrenochrome causes schizophrenia in order to ask whether Hoffer identified several biologically important relationships deserving further investigation:
stress influences catecholamine metabolism;
catecholamines undergo oxidation;
vitamin B3 participates intimately in cellular redox and energy metabolism;
and
individual nutritional and metabolic differences may influence vulnerability to physiological stress.
Modern science permits these questions to be examined with biochemical tools Hoffer did not possess.
That brings the discussion back to childbirth. The postpartum period combines unusually rapid hormonal change, physiological stress, sleep disruption, altered immune activity, nutritional demands, and major changes in tryptophan and niacin metabolism. If there were ever a physiological state in which to reconsider Hoffer's broader proposition that stress, nutrient availability, and individual biochemical vulnerability can interact to influence psychiatric illness, the period immediately following pregnancy presents an unusually interesting test case.
Part 3. Pregnancy, Tryptophan, and Vitamin B3 Metabolism
If Hoffer's theory is to have any relevance to postpartum mental illness, there must first be a plausible connection between vitamin B3 metabolism and pregnancy. Modern nutritional research provides such a connection, although it does not establish Hoffer's psychiatric conclusions. Pregnancy produces substantial changes in the way the mother's body handles tryptophan and converts it through metabolic pathways related to niacin and NAD+.
Understanding this requires beginning with tryptophan.
Tryptophan: An Essential Nutrient
Tryptophan is one of the essential amino acids. Unlike many substances required by the human body, it cannot be manufactured from other nutrients in sufficient amounts and therefore must come from the diet. Its principal sources are protein-rich foods, including meat, poultry, fish, eggs, milk and other dairy products, as well as plant sources such as soybeans and other legumes, nuts, seeds, and whole grains. A varied diet containing adequate protein will ordinarily provide sufficient tryptophan. This dependence upon food, however, becomes important when considering pregnancy and lactation, since the mother's physiological requirements are increasing while the original supply of tryptophan remains dietary.
Once absorbed, tryptophan has several possible destinations. Much of it is incorporated into proteins. A smaller portion contributes to the production of serotonin and subsequently melatonin. Most of the tryptophan that is metabolized rather than incorporated into protein, however, enters what is known as the kynurenine pathway.
In simplified form:
Dietary protein
↓
Tryptophan
↓
Kynurenine pathway
↓
several intermediate metabolites
↓
Quinolinic acid
↓
NAD+
NAD+, or nicotinamide adenine dinucleotide, is indispensable to cellular life. It participates in energy metabolism, oxidation-reduction reactions, DNA repair, cellular signaling, and numerous enzymatic processes.
Vitamin B3 provides another route into this system. Niacin and nicotinamide can be converted into NAD+ without first requiring the body to manufacture the niacin equivalent from tryptophan.
The body therefore possesses two related nutritional sources for maintaining its niacin/NAD system: preformed vitamin B3 obtained from the diet and endogenous production derived from dietary tryptophan.
This relationship is reflected in the nutritional concept of the niacin equivalent. In ordinary adults, approximately 60 milligrams of dietary tryptophan is conventionally considered capable of supplying about one milligram of niacin equivalent, although actual conversion varies considerably according to physiological and nutritional conditions. (ods.od.nih.gov)
This variability becomes especially important during pregnancy.
Pregnancy Changes the Conversion of Tryptophan
Pregnancy does not merely increase the amount of food a woman requires. It alters the way certain nutrients are metabolized.
Researchers studying tryptophan and niacin metabolism have found a particularly striking example. During pregnancy, the conversion of tryptophan through the kynurenine-niacin pathway becomes substantially more active.
A study involving 434 pregnant Japanese women measured urinary metabolites associated with tryptophan and niacin metabolism throughout pregnancy. The investigators found that several metabolites increased substantially as pregnancy progressed. By late pregnancy, urinary nicotinamide metabolites were approximately two to three times the values found in nonpregnant women. (pubmed.ncbi.nlm.nih.gov)
This finding needs to be stated carefully. It does not mean that a pregnant woman simply has three times as much vitamin B3 circulating in her blood. Rather, it demonstrates that pregnancy markedly increases activity within the metabolic system by which tryptophan contributes to niacin-related metabolites.
Earlier human studies had observed the same general phenomenon. Pregnancy increases the apparent efficiency with which dietary tryptophan is converted into niacin metabolites, particularly during the later stages of gestation.
This is a remarkable physiological adaptation.
The mother is supporting a rapidly growing fetus while simultaneously undergoing major changes in her own tissues, blood volume, endocrine system, and energy requirements. Increased ability to derive niacin equivalents from tryptophan may therefore represent one of the body's adaptations to the metabolic demands of pregnancy.
Why Does Pregnancy Increase This Conversion?
Hormones appear to be important.
Experimental and human evidence has long suggested that estrogen can increase the activity of enzymes involved in tryptophan metabolism, particularly pathways leading toward niacin formation. Pregnancy produces extraordinarily high concentrations of estrogen compared with the nonpregnant state.
Other pregnancy-related hormonal and metabolic changes may also influence the kynurenine pathway. The process is therefore more complicated than a single hormone turning a single enzyme on or off.
Nevertheless, the broad observation is well established:
Nonpregnant state
↓
baseline tryptophan-niacin metabolism
Pregnancy progresses
↓
major hormonal and metabolic changes
↓
increased tryptophan metabolism through the kynurenine-niacin pathway
Late pregnancy
↓
markedly increased production of niacin-related metabolites.
Then comes childbirth.
The Metabolic Transition at Delivery
Delivery produces an abrupt endocrine transition.
During pregnancy, the placenta functions as an enormous endocrine organ. Estrogen and progesterone concentrations become far higher than those normally experienced outside pregnancy. Once the placenta is delivered, the source of much of this hormonal production disappears.
Estrogen and progesterone consequently fall dramatically during the first days following childbirth.
At approximately the same time, the enhanced tryptophan-niacin metabolism characteristic of pregnancy begins moving back toward the nonpregnant state. Studies measuring urinary niacin metabolites have found that the unusually high levels observed during pregnancy decline following delivery. (pubmed.ncbi.nlm.nih.gov)
The mother's metabolism therefore does not simply continue its late-pregnancy configuration after the child is born.
There is a transition:
Late pregnancy
↓
high estrogen and other pregnancy hormones
↓
enhanced tryptophan → kynurenine → niacin/NAD-related metabolism
↓
delivery of the placenta
↓
rapid hormonal change
↓
decline toward the nonpregnant pattern of tryptophan-niacin metabolism.
This transition is particularly interesting because it occurs during precisely the period when postpartum psychiatric disorders can begin.
That temporal association does not demonstrate causation. Most women undergo these metabolic changes without developing depression or psychosis. Any viable hypothesis must therefore explain susceptibility, rather than treating normal postpartum physiology itself as pathological.
The Importance of Dietary Tryptophan
Here another variable enters the picture.
The human body cannot manufacture tryptophan. Whatever metabolic advantages pregnancy provides in converting tryptophan into niacin-related compounds, the original tryptophan must still ultimately come from the mother's diet.
This raises an important distinction between metabolic efficiency and nutrient availability.
A metabolic pathway can become highly efficient while still being limited by the amount of starting material available to it.
Imagine two pregnant women whose hormonal systems both substantially increase tryptophan-to-niacin conversion. One consumes abundant high-quality protein and has ample tryptophan available. The other has marginal protein or tryptophan intake, poor appetite, dietary restriction, malabsorption, prolonged nausea, or some other factor reducing nutrient availability.
Their metabolic pathways may be similarly stimulated by pregnancy, yet the amount of substrate available to those pathways may differ considerably.
This suggests a potentially important variable that is easily overlooked when discussing vitamin B3:
How much tryptophan does the mother actually have available?
Pregnancy itself increases the recommended intake of tryptophan. The adult requirement is conventionally estimated at approximately 5 mg/kg of body weight per day, while the pregnancy recommendation rises to approximately 7 mg/kg/day. (nationalacademies.org)
In a healthy woman consuming adequate protein, this requirement is ordinarily achievable. The hypothesis being considered here therefore does not require assuming that pregnant women are generally tryptophan deficient.
Rather, it raises the possibility that individual variation in dietary intake, absorption, metabolism, and physiological demand could matter in susceptible women.
Tryptophan Has Competing Destinations
There is another complication. Tryptophan used in one metabolic process is not simultaneously available for another.
Tryptophan is needed for:
protein synthesis;
serotonin and melatonin synthesis;
and
kynurenine metabolism, including eventual contribution to NAD+ production.
This does not mean these pathways simply compete according to a fixed formula. They are tightly regulated by enzymes, hormones, immune signals, nutrient availability, and physiological conditions.
But it does mean that measuring dietary tryptophan alone may not tell us what is happening.
Two women could consume similar amounts while metabolizing that tryptophan differently.
Inflammatory activity, stress hormones, pregnancy hormones, vitamin and mineral status, and enzyme activity can alter the proportion entering different metabolic pathways.
This becomes especially important when considering postpartum depression.
Low Tryptophan and Postpartum Depression
Modern research has found an intriguing association between early postpartum tryptophan concentrations and subsequent mood disturbance.
A systematic review and meta-analysis examining amino acids and postpartum depression found that lower total blood tryptophan during approximately the first five days after delivery was significantly associated with postpartum depression. The investigators considered early postpartum tryptophan sufficiently interesting to warrant further investigation as a potential biomarker. (pubmed.ncbi.nlm.nih.gov)
Older studies provide additional evidence that the immediate postpartum period involves unusual tryptophan dynamics.
In women who did not develop postpartum blues, plasma tryptophan tended to rise during the first days following childbirth. In women experiencing postpartum blues, this expected rise was diminished or absent. Investigators proposed that continued degradation of tryptophan through the kynurenine pathway might help explain the difference. (pubmed.ncbi.nlm.nih.gov)
Again, these findings do not establish that low tryptophan causes postpartum depression.
Low circulating tryptophan might be a cause, a consequence, a marker of inflammation or altered metabolism, or some combination of these factors.
Nevertheless, the association is important because it independently brings modern postpartum research remarkably close to the nutritional pathway that interested Hoffer.
A Possible Nutritional Bottleneck
We can now formulate a more precise question.
During late pregnancy, the mother's physiology substantially increases tryptophan metabolism toward niacin-related products. After delivery, that metabolic adaptation begins changing rapidly. At the same time, some women show unusually low circulating tryptophan during the period associated with postpartum mood disturbance.
Suppose a susceptible woman enters this transition with marginal availability of either tryptophan, preformed vitamin B3, or both.
Her body has several possible sources and demands:
Dietary tryptophan
→ proteins
→ serotonin/melatonin
→ kynurenine pathway → NAD+
while
Dietary vitamin B3
→ nicotinamide
→ NAD+.
This suggests an interesting possibility.
If adequate preformed B3 is available, the body possesses a nutritional route to NAD+ that does not require first deriving the niacin equivalent from tryptophan. Conversely, if dietary B3 is marginal, maintaining the NAD system may place greater importance upon tryptophan metabolism.
This does not demonstrate that niacin supplementation would "free" enough tryptophan to increase brain serotonin. Human metabolism is far too regulated and complicated for that conclusion to follow automatically.
It does, however, produce a testable hypothesis:
Could the balance between dietary tryptophan, preformed vitamin B3, and the postpartum kynurenine-NAD pathway influence psychiatric vulnerability in a subgroup of women?
Why This Matters for Hoffer's Theory
Hoffer did not possess today's understanding of the kynurenine pathway, NAD biology, inflammatory signaling, or postpartum metabolism. Yet one of his central propositions was that psychiatric vulnerability might emerge when individual biochemical requirements exceed what conventional nutritional standards regard as adequate.
Modern pregnancy research gives that proposition an unusually interesting setting in which to be reconsidered.
The mother's handling of tryptophan and niacin changes dramatically during pregnancy. The change is measurable. It becomes particularly pronounced during late pregnancy and then reverses following childbirth.
At approximately the same time, a susceptible minority of women develops profound changes in mood, perception, or thought.
None of this proves Hoffer's theory.
But it gives us something more substantial than a superficial resemblance between schizophrenia and postpartum psychosis. It identifies an actual biochemical system involving vitamin B3 that changes markedly across pregnancy and childbirth, while independent psychiatric research identifies abnormalities in another part of that same tryptophan system among women experiencing postpartum mood disturbance.
The next question is therefore what happens when this metabolic transition encounters the extraordinary physiological conditions immediately following childbirth: the collapse of pregnancy hormones, inflammation and immune adjustment, physical recovery, stress, and perhaps most importantly, severe disruption of sleep.
Part 4. The Postpartum Transition: Hormones, Stress, Sleep, and Tryptophan Metabolism
Childbirth does not merely end pregnancy. It initiates another major physiological state.
Within a remarkably short period, the mother's endocrine environment changes dramatically. She must recover physically from pregnancy and delivery, frequently begins lactation, and assumes the demands of caring for a newborn. Sleep may become fragmented almost immediately. Psychological and physical stress can increase at precisely the time that the metabolic adaptations of pregnancy are being reversed.
For most women these changes do not result in serious psychiatric illness. Yet in a susceptible minority, the weeks following childbirth represent a period of unusual psychiatric vulnerability. Postpartum psychosis is particularly striking because its onset is frequently rapid and closely associated with childbirth. A recent expert consensus review describes postpartum psychosis as a severe illness generally beginning within weeks of delivery and emphasizes the profound endocrine, immune, neurological, and physiological changes occurring during this period. Modern evidence also indicates that postpartum psychosis is strongly related to the bipolar spectrum rather than ordinarily representing schizophrenia appearing after childbirth.
This distinction is important when reconsidering Hoffer. His adrenochrome hypothesis was developed primarily as an explanation for schizophrenia. It would therefore be unjustified simply to relabel postpartum psychosis as another form of Hoffer's schizophrenia.
The more interesting question is whether some of the biochemical relationships Hoffer emphasized—stress, catecholamine activity, oxidation, nutritional status, and individual metabolic susceptibility—might have relevance to the extraordinary physiological transition following childbirth.
The Hormonal Change After Delivery
During pregnancy, concentrations of reproductive hormones rise to levels rarely encountered during any other period of normal adult life. Estradiol may increase approximately fiftyfold and progesterone approximately tenfold compared with the nonpregnant state. After delivery of the placenta, these hormones decline rapidly toward their pre-pregnancy concentrations.
This dramatic hormonal withdrawal has long been investigated as a possible contributor to postpartum depression.
The relationship is not as simple as saying that women with postpartum depression have lower estrogen or progesterone concentrations than other mothers. Studies measuring absolute hormone concentrations have produced inconsistent results. A more interesting possibility is that some women are unusually sensitive to the hormonal transition itself.
An influential experiment illustrated this distinction. Researchers experimentally reproduced pregnancy-like concentrations of estradiol and progesterone and then withdrew the hormones. Women with a previous history of postpartum depression developed significant mood symptoms during withdrawal, whereas women without such a history did not. Importantly, the difference appeared to involve the women's response to hormonal change rather than simply different hormone concentrations.
This provides an important principle for the hypothesis developed in this paper:
The same physiological event can produce very different consequences in different individuals.
Every mother undergoes substantial hormonal changes after delivery. Only a minority develops serious depression or psychosis. The important question may therefore concern biological susceptibility to a normal postpartum transition, rather than the presence of an abnormal transition itself.
That principle resembles an important element of Hoffer's thinking. Hoffer did not propose that ordinary adrenaline caused everyone to become psychotic. He proposed that a biochemical vulnerability could make an otherwise normal physiological substance or pathway problematic in certain individuals.
Childbirth as a Physiological Stress
Delivery itself represents substantial physical stress.
Labor involves pain, muscular exertion, catecholamine activity, inflammatory processes, and frequently prolonged wakefulness. Depending upon the individual birth, the mother may additionally experience blood loss, surgery, anesthesia, infection, tissue injury, or other complications.
The demands do not necessarily cease when delivery is complete.
Within hours the mother may begin feeding and caring for an infant around the clock while simultaneously recovering from childbirth. Appetite and normal eating schedules can be disrupted. Anxiety concerning the infant may increase. Breastfeeding can require repeated waking throughout the night.
The postpartum period can therefore combine several different forms of stress:
physical recovery from childbirth;
rapid endocrine change;
nutritional demands;
emotional responsibility for the infant;
repeated interruption of sleep;
and, in some cases, significant medical complications.
These stresses need not be pathological individually. Their importance may lie in their occurring simultaneously during a period of profound metabolic adjustment.
Sleep Deprivation: A Particularly Important Variable
Among these factors, sleep deserves special attention.
Newborn infants do not ordinarily conform to an adult day-night schedule. Feeding, crying, changing, and comforting can divide the mother's sleep into short intervals. A woman who previously slept seven or eight continuous hours may suddenly receive sleep in fragments distributed throughout the night and day.
Sleep disturbance is extremely common after childbirth, but researchers have become particularly interested in its relationship to postpartum psychosis.
As early as 2003, a review proposed that sleep loss might represent a "final common pathway" through which several different postpartum risk factors precipitate psychosis in susceptible women. More recent reviews continue to find an association between insomnia, sleep loss, circadian disruption, and postpartum psychosis, although an important question remains unresolved: is sleep disruption causing psychiatric deterioration, or is emerging psychiatric illness itself preventing the woman from sleeping? Both processes may occur.
The association with bipolar illness makes this particularly important. Sleep deprivation is a recognized precipitant of mania in susceptible individuals, and modern evidence increasingly places postpartum psychosis within the bipolar spectrum.
This gives us a plausible feedback mechanism:
newborn care
↓
fragmented maternal sleep
↓
increased physiological and psychological stress
↓
greater difficulty sleeping
↓
further sleep loss
For a vulnerable woman, this cycle could potentially contribute to progressively worsening mood instability.
Stress and Tryptophan Metabolism
Sleep and stress also return us to the biochemical pathway discussed in Part 3.
Modern research has identified an important relationship between stress, immune-inflammatory activity, and tryptophan metabolism. Increased stress hormones and inflammatory signaling can increase metabolism of tryptophan through the kynurenine pathway, potentially changing the balance between tryptophan available for serotonin and melatonin synthesis and tryptophan entering kynurenine metabolism.
This is particularly relevant because kynurenine is not merely an intermediate step on the way to NAD+.
The pathway produces several biologically active compounds. Two particularly important examples are kynurenic acid and quinolinic acid. These compounds affect glutamate signaling and other aspects of nervous-system function in different ways. Consequently, increased movement of tryptophan through the kynurenine pathway cannot automatically be regarded as either beneficial or harmful. The consequences depend partly upon which branches of the pathway become active and which metabolites accumulate.
Modern researchers have therefore proposed that altered tryptophan metabolism may contribute to postpartum depression through interactions among stress hormones, inflammation, serotonin, melatonin, and neuroactive kynurenine metabolites.
This provides a potentially important connection with the observations discussed in Part 3.
The postpartum mother may simultaneously experience:
declining pregnancy-enhanced niacin metabolism;
altered tryptophan metabolism;
rapid hormonal withdrawal;
immune and inflammatory changes;
sleep disruption;
and
increased psychological and physiological stress.
These processes are not independent. They interact.
Returning to Hoffer: Stress and Adrenaline
At this point Hoffer's theory becomes relevant again.
Hoffer and Osmond were particularly interested in adrenaline metabolism during states of stress. Their hypothesis proposed that excessive or abnormal oxidation of adrenaline could produce adrenochrome and related aminochromes capable of disturbing brain function in susceptible individuals.
A simplified Hoffer-style model would therefore be:
stress
↓
increased catecholamine activity
↓
adrenaline
↓ oxidation
adrenochrome and related compounds
↓
neurological disturbance in a susceptible individual
There is no established evidence that this sequence explains postpartum depression or postpartum psychosis.
That limitation must be emphasized.
The fact that stress increases catecholamine activity does not demonstrate that postpartum stress produces pathological quantities of adrenochrome in the brain. Nor has adrenochrome been demonstrated to cause postpartum psychiatric illness.
Nevertheless, childbirth provides an intriguing environment in which to reconsider Hoffer's broader biochemical reasoning.
The mother experiences unusually rapid hormonal and metabolic changes while simultaneously being exposed to substantial physical and psychological stress. If Hoffer was correct that certain individuals differ significantly in their ability to handle oxidative products of catecholamine metabolism, postpartum physiology might theoretically expose such a vulnerability.
This remains a hypothesis, but unlike Hoffer in the 1950s, modern investigators could potentially measure many of the relevant variables.
Two Pathways May Be Responding to the Same Stress
An especially interesting possibility emerges when Hoffer's hypothesis is placed beside modern tryptophan research.
Stress could potentially influence two different biochemical systems at the same time.
One is well supported:
stress / inflammatory signaling
↓
altered tryptophan metabolism
↓
kynurenine pathway
↓
changes in serotonin/melatonin availability and neuroactive kynurenine metabolites.
The second is Hoffer's proposed pathway:
stress
↓
catecholamine activity
↓
adrenaline oxidation
↓
adrenochrome/aminochromes
↓
possible neurological effects.
The first pathway has substantial modern research behind it in relation to postpartum depression. The second remains speculative as an explanation of psychiatric disease.
But they need not be mutually exclusive hypotheses.
Stress is a whole-body physiological response. The same sleep deprivation and psychological strain could affect endocrine signaling, inflammatory pathways, catecholamine metabolism, tryptophan metabolism, oxidative balance, and cellular energy requirements simultaneously.
That suggests a broader model than Hoffer originally possessed.
The Possibility of a Biochemical Feedback Loop
Consider a susceptible mother during the first weeks following childbirth.
Her pregnancy hormones fall rapidly.
Her enhanced pregnancy-related tryptophan-niacin metabolism is moving toward its nonpregnant state.
She is physically recovering from delivery.
Her sleep is repeatedly interrupted.
She becomes increasingly tired.
Fatigue and anxiety increase her physiological stress.
Stress and inflammatory signaling alter tryptophan metabolism.
Poor sleep further affects mood and circadian regulation.
Increasing anxiety makes sleep still more difficult even when the infant is sleeping.
A self-reinforcing cycle becomes possible:
childbirth and hormonal transition
↓
sleep disruption + physical stress
↓
altered stress and inflammatory signaling
↓
altered tryptophan/kynurenine metabolism
↓
mood and sleep disturbance
↓
greater stress and poorer sleep
↓
further metabolic disturbance
This model does not require any one factor to be the sole cause of postpartum illness.
Indeed, that may be its principal advantage.
It treats postpartum psychiatric vulnerability as the possible result of several interacting physiological pressures occurring simultaneously in a susceptible individual.
Where Vitamin B3 Might Enter the Model
Vitamin B3 now becomes interesting for reasons somewhat different from Hoffer's original adrenochrome theory.
Niacin and nicotinamide are precursors for NAD+, while tryptophan can also contribute to NAD+ through the kynurenine pathway. NAD+ in turn participates in cellular energy metabolism, redox reactions, DNA repair, and numerous stress-response processes.
If a postpartum woman has ample nutritional reserves, these demands may present no difficulty.
But suppose another woman begins the postpartum period with relatively marginal tryptophan or B3 availability. Then add physical recovery, lactation, poor appetite, repeated waking, psychological stress, inflammation, and altered tryptophan metabolism.
The question becomes:
Could marginal nutritional status reduce the physiological reserve available for coping with an unusually demanding metabolic transition?
That proposition is considerably more modest than saying that niacin deficiency causes postpartum depression.
It also produces predictions that could be tested.
Women developing postpartum illness could be compared with healthy postpartum controls for dietary intake, circulating tryptophan, kynurenine metabolites, niacin metabolites, NAD-related measures, inflammatory markers, stress hormones, and objective measures of sleep.
If no meaningful differences emerged, this aspect of the hypothesis would be weakened.
If a reproducible metabolic pattern appeared before or during the development of symptoms, however, it would justify controlled intervention studies.
The Missing Participant: The Infant
There is one important element still absent from this model.
The postpartum mother is not undergoing these changes in isolation.
If she is breastfeeding, she is supplying nutrients continuously to another rapidly growing human being. Her nutritional requirements therefore do not simply return to their nonpregnant state when pregnancy ends. Some requirements remain elevated or change because of lactation.
The infant also determines much of the mother's sleep.
A calm infant who sleeps for relatively long intervals presents a very different physiological burden from an infant who wakes and cries repeatedly throughout the night.
This raises the possibility of a second feedback system in which maternal nutrition, breast-milk composition, infant nutrition and behavior, maternal sleep, and maternal stress interact.
That possibility is particularly relevant to vitamin B3 because niacin and related B3 compounds are transferred into human milk and maternal intake can influence their concentrations.
The mother-infant relationship therefore deserves to be examined not merely psychologically, but as a connected nutritional and metabolic system.
That is the subject of the next section.
Part 5. Breastfeeding and the Mother–Infant Nutritional System
Once the child is born, pregnancy ends, but the mother's nutritional contribution to her infant may continue through breastfeeding. The placenta has been removed, yet mother and child remain biologically connected through human milk. This introduces an important consideration into the postpartum hypothesis: the mother's nutritional resources are now supporting not only her own recovery and metabolism but also, to varying degrees, the nutritional requirements of a rapidly growing infant.
This relationship is especially interesting in the case of vitamin B3.
As discussed previously, pregnancy substantially alters maternal tryptophan-niacin metabolism. Following delivery, that unusual pregnancy metabolism begins returning toward the nonpregnant state. Yet the mother's nutritional demands do not simply return to their pre-pregnancy level. If she breastfeeds, she enters another nutritionally demanding physiological state: lactation.
The recommended niacin intake illustrates this point. For an adult woman, the recommended intake is approximately 14 mg niacin equivalents (NE) per day. During pregnancy it rises to 18 mg NE, and during lactation it remains elevated at approximately 17 mg NE per day.
The mother therefore moves directly from one state of increased B3 requirement into another.
Vitamin B3 Passes into Human Milk
Vitamin B3 occurs in human milk principally in forms related to nicotinamide metabolism. Because B vitamins are water-soluble, their concentrations in breast milk can be more responsive to maternal nutritional intake than many other nutrients. Reviews of maternal micronutrient nutrition have found that human-milk concentrations of water-soluble vitamins are generally among those most affected by maternal intake or status.
This means that the mammary gland does not necessarily maintain an identical concentration of every vitamin in milk regardless of what the mother consumes.
Recent evidence concerning vitamin B3 makes this particularly clear.
A large randomized, placebo-controlled study in Tanzania examined 1,173 mother-child pairs. Lactating mothers were assigned to receive either placebo or 250 mg of nicotinamide per day, beginning when their infants were less than two weeks old and continuing for six months.
Maternal supplementation produced a striking change in breast milk.
Median total vitamin B3 concentrations in human milk were approximately 291 percent higher at one month and 281 percent higher at five months in supplemented mothers than in mothers receiving placebo.
This experiment establishes an important point for the present hypothesis:
maternal vitamin B3 intake can substantially influence the amount of B3-related compounds appearing in human milk.
The same study also provides an important caution. Although supplementation markedly increased milk B3 concentrations, investigators found no association between milk B3 concentrations and the children's subsequent growth, head circumference, or measured cognitive development through eighteen months.
Higher breast-milk B3 therefore should not automatically be assumed to produce better infant outcomes.
Nevertheless, the experiment demonstrates that the maternal and infant B3 systems are nutritionally connected.
The Newborn Has an Interesting Limitation
The nutritional physiology of the young infant adds another important element.
Adults can obtain niacin in two ways:
preformed vitamin B3 from food
and
conversion of dietary tryptophan into niacin equivalents.
For nutritional calculations in adults, approximately 60 mg of tryptophan is conventionally regarded as equivalent to about 1 mg of niacin.
Young infants are different.
The NIH Office of Dietary Supplements explains that infants during the first six months use so much of their dietary protein for growth and development that their recommended niacin intake is based upon preformed niacin rather than assuming substantial conversion from tryptophan.
For infants from birth through six months, the Adequate Intake is approximately 2 mg of niacin per day.
This is particularly interesting in relation to the hypothesis developed here.
The mother possesses considerable capacity to use dietary tryptophan as a source of niacin equivalents. Her newborn appears to depend much more directly upon the B3 supplied in milk or formula.
In a breastfed infant, that B3 ultimately originates from the mother's nutritional and metabolic system.
We can therefore describe a nutritional chain:
maternal diet
↓
maternal B3 and tryptophan metabolism
↓
vitamin B3 compounds in breast milk
↓
infant B3 intake
The 2026 supplementation experiment demonstrates experimentally that at least one important link in this chain—maternal B3 intake → breast-milk B3 concentration—is real.
What If the Mother's Intake Is Marginal?
This raises a reasonable question.
What happens if a breastfeeding mother begins lactation with marginal B3 or tryptophan intake?
In a well-nourished woman eating an adequate diet, there may be no difficulty at all. Vitamin B3 is widely available in food, and tryptophan is supplied by many protein-rich foods. The purpose of this hypothesis is not to suggest that breastfeeding ordinarily causes niacin deficiency.
Instead, the question concerns women who may begin near the lower margin.
Consider a mother who has experienced prolonged nausea during pregnancy, restricted food intake, poor-quality diet, low protein consumption, malabsorption, significant blood loss or illness, or simply poor appetite during the stressful weeks surrounding childbirth.
She now enters lactation while simultaneously recovering from pregnancy and delivery.
If her nutritional reserves or intake are marginal, there are potentially two subjects of interest:
the mother herself
and
the infant receiving her milk.
The mother's own B3 and tryptophan status could theoretically influence her ability to meet metabolic demands. At the same time, maternal intake can influence B3 concentrations in her milk.
This produces an important research question:
Could a subgroup of breastfeeding mothers and their infants simultaneously experience marginal B3 availability?
The existing evidence does not answer that question, but it makes the question testable.
The Colic Question
At this point we reach the most speculative portion of the proposed mother-infant feedback loop.
Could marginal infant vitamin B3 status contribute to irritability, poor sleep, excessive crying, or what parents commonly call colic?
At present, there is no convincing evidence that ordinary infantile colic is caused by vitamin B3 deficiency.
That fact should be stated plainly.
Infantile colic is not a single clearly understood disease. It is generally defined by prolonged and otherwise unexplained crying in an apparently healthy infant. Proposed contributors include gastrointestinal immaturity, feeding difficulties, cow's-milk protein sensitivity in some infants, altered gut motility, microbiome differences, and developmental regulation of the nervous system.
Diet can matter in at least some cases. For example, research has identified a subgroup of infants whose colic appears related to cow's-milk protein, while trials of certain probiotic interventions have reported reductions in crying among some breastfed infants.
None of this establishes a connection with vitamin B3.
The B3-colic proposition must therefore remain a hypothesis to be tested, not a conclusion.
Yet there is a reason it deserves investigation rather than dismissal.
Niacin-derived NAD+ is fundamental to cellular energy metabolism and nervous-system function. The young infant is growing extraordinarily rapidly and, during the first six months, depends comparatively heavily upon preformed dietary niacin. Meanwhile, maternal intake demonstrably influences B3 concentrations in breast milk.
It would therefore be reasonable to ask whether infants at the lower end of B3 status differ in crying duration, irritability, feeding behavior, or sleep from infants with higher status.
That experiment apparently has not been adequately performed.
The Infant as a Source of Maternal Stress
The importance of infant crying extends beyond the infant.
A newborn who cries frequently changes the mother's physiological environment.
Consider two mothers whose deliveries and nutritional status are otherwise similar.
One infant feeds predictably and sleeps for relatively long intervals.
The other infant wakes repeatedly, cries for prolonged periods, has difficulty settling, and requires almost continuous attention during portions of the night.
The second mother is likely to experience substantially greater disruption of sleep and greater psychological stress.
The infant's behavior therefore becomes part of the mother's postpartum physiology.
This creates the possibility of a feedback loop:
infant discomfort or irritability
↓
increased crying and waking
↓
maternal sleep interruption
↓
maternal fatigue and stress
↓
greater difficulty sleeping even when given the opportunity
↓
increasing physiological and psychological strain
This portion of the cycle requires no B3 hypothesis. A persistently wakeful or distressed infant can disrupt parental sleep regardless of why the infant is crying.
The nutritional hypothesis asks an additional question:
Could maternal and infant nutrition occasionally contribute to the event that begins or intensifies that cycle?
A Hypothetical B3 Mother–Infant Feedback Loop
We can now state the complete hypothesis in its strongest defensible form.
Suppose a mother begins the postpartum period with marginal tryptophan and/or B3 availability.
After delivery, the unusually enhanced tryptophan-niacin metabolism of pregnancy declines.
At the same time, lactation maintains an increased requirement for B3 and other nutrients.
Maternal intake influences B3 concentrations in breast milk.
The young infant depends substantially upon preformed dietary niacin.
If marginal infant B3 status contributed to irritability or poor sleep—an unproven step—the infant might cry and wake more frequently.
The mother would consequently sleep less.
Sleep deprivation and psychological stress could increase physiological stress responses and alter inflammatory and tryptophan metabolism.
Her mood, appetite, and ability to maintain regular meals might deteriorate.
Poorer nutrition could then further aggravate the original nutritional problem.
The proposed cycle would look like this:
marginal maternal B3 / tryptophan
↓
postpartum metabolic transition + lactation
↓
lower maternal nutritional reserve
↓
potentially lower breast-milk B3
↓
marginal infant B3 status
↓
possible infant irritability / poor sleep
(hypothetical)
↓
more crying and maternal waking
↓
maternal sleep deprivation + stress
↓
altered stress, inflammatory, and tryptophan metabolism
↓
poorer maternal mood, appetite, and sleep
↓
greater nutritional and physiological stress
The importance of this model is not that every arrow has been demonstrated. They have not.
Its value is that most of the individual variables can be measured.
A Two-Person Metabolic System
Postpartum psychiatric research understandably concentrates on the mother. Pediatric research concentrates on the infant.
Yet during breastfeeding these are not completely independent biological systems.
Maternal diet can influence components of human milk. Human milk supplies the infant. Infant feeding, health, crying, and sleep affect maternal sleep and stress. Maternal sleep and stress, in turn, affect maternal physiology, mood, appetite, and possibly lactation.
The relationship is therefore bidirectional:
MOTHER → MILK → INFANT
but also
INFANT → CRYING/SLEEP → MATERNAL STRESS
and then potentially back again.
Thinking of mother and infant as a temporarily interconnected nutritional, behavioral, and metabolic system may reveal relationships that disappear when each is studied separately.
An Important Clue—and an Important Warning
The recent Tanzanian trial provides an unusually useful clue because it demonstrates that maternal nicotinamide supplementation can produce a very large increase in breast-milk B3 concentrations. But it simultaneously warns against assuming that more B3 must necessarily be better: the study did not find corresponding improvements in the measured child growth or developmental outcomes.
The next step therefore should not be indiscriminate high-dose supplementation of breastfeeding mothers or infants.
It should be measurement.
A well-designed prospective study could begin during late pregnancy and follow mother-infant pairs through the first several postpartum months. Researchers could measure maternal dietary tryptophan and B3 intake, maternal B3 metabolites, maternal tryptophan and kynurenine metabolites, breast-milk B3 concentrations, infant B3 status, infant feeding, crying and sleep, and maternal sleep and psychiatric symptoms.
The temporal sequence would be particularly important.
If low maternal B3 status appeared before lower milk B3, followed by lower infant status, followed by increased infant irritability and maternal sleep loss, the proposed feedback loop would become substantially more credible.
If no such relationship appeared, the B3-colic portion of the hypothesis would be weakened or rejected.
Either result would be useful.
The purpose of the hypothesis is therefore not to declare that vitamin B3 deficiency causes infant colic or postpartum depression. It is to recognize an unusual convergence of facts: pregnancy markedly alters tryptophan-niacin metabolism; lactation maintains increased maternal B3 requirements; maternal supplementation can markedly alter B3 concentrations in human milk; young infants depend substantially upon preformed niacin; and infant sleep and crying directly influence maternal sleep and stress.
Whether these observations form a clinically important chain remains unknown.
That distinction—between what has actually been demonstrated and what this paper proposes as a testable extension of those findings—is essential as we evaluate the evidence for the larger hypothesis.
Part 6. A Proposed Postpartum Metabolic Feedback Loop
The preceding sections have examined several processes that are usually studied separately: Hoffer's theory of biochemical vulnerability, the unusual metabolism of tryptophan and vitamin B3 during pregnancy, the abrupt hormonal transition following delivery, postpartum stress and sleep deprivation, lactation, and the nutritional connection between mother and infant.
Taken together, these observations suggest a broader hypothesis.
Postpartum psychiatric illness may not always arise from a single biochemical defect. In a susceptible woman, it may instead develop when several individually manageable stresses occur simultaneously and begin reinforcing one another.
The central concept is therefore not simply niacin deficiency.
It is loss of metabolic reserve during an unusually demanding physiological transition.
Pregnancy Creates an Unusual Metabolic State
During pregnancy, the mother's body undergoes extensive adaptation. Among these changes is a substantial increase in the metabolism of tryptophan through pathways producing niacin-related metabolites. By late pregnancy, some urinary nicotinamide metabolites reach approximately two to three times their nonpregnant values.
This enhanced state does not continue indefinitely.
Delivery of the placenta is followed by a rapid decline in pregnancy hormones, while the unusual tryptophan-niacin metabolism of pregnancy begins returning toward the nonpregnant condition.
Thus the mother passes rapidly from:
late pregnancy
→ high reproductive hormones
→ enhanced tryptophan-niacin metabolism
→ fetal nutritional demands
into:
early postpartum
→ abrupt hormonal withdrawal
→ changing tryptophan metabolism
→ recovery from childbirth
→ lactation
→ interrupted sleep
→ responsibility for a newborn.
The transition occurs over days rather than months.
For most women this transition is successfully accommodated. The hypothesis proposed here concerns women whose nutritional, metabolic, genetic, hormonal, psychiatric, or environmental circumstances leave them with less reserve for adapting to it.
The First Vulnerability: Nutrient Availability
Tryptophan provides a particularly interesting example because it cannot be synthesized by the human body.
The mother must obtain it from food.
Once available, tryptophan has several important destinations. It is needed for protein synthesis and can contribute to serotonin and melatonin production, while much of metabolized tryptophan enters the kynurenine pathway, which ultimately can contribute to NAD+ synthesis.
Vitamin B3 provides another route into NAD metabolism.
This creates a metabolic relationship:
dietary tryptophan
→ protein
→ serotonin/melatonin
→ kynurenine pathway → NAD+
while
dietary vitamin B3
→ nicotinamide
→ NAD+.
A woman consuming adequate protein and vitamin B3 may have ample nutritional capacity for these processes.
But women differ.
Poor appetite, restricted diets, prolonged pregnancy nausea, gastrointestinal disorders, socioeconomic circumstances, food preferences, illness, or simply inadequate intake could leave one woman closer to the nutritional margin than another.
The important question is therefore not whether the average postpartum woman receives enough tryptophan or B3.
It is whether a vulnerable subgroup does not.
The Second Vulnerability: The Postpartum Metabolic Shift
Immediately following childbirth, the biochemical environment changes.
The enhanced tryptophan-niacin metabolism associated with pregnancy begins diminishing. At the same time, research has found that some women experiencing postpartum mood disturbance have unusually low circulating tryptophan or abnormal patterns of kynurenine metabolism.
This creates a potential metabolic bottleneck.
A woman with abundant nutritional reserves might accommodate the change without difficulty.
A woman already near the margin might not.
Importantly, this hypothesis does not require a classical vitamin deficiency such as pellagra. Hoffer's broader concept was that an individual could have enough of a nutrient to prevent a recognized deficiency disease while still possessing an unusually high biochemical requirement under particular circumstances.
Whether that proposition applies to postpartum illness remains unknown, but pregnancy provides an unusually appropriate physiological setting in which to test it because nutrient metabolism is demonstrably changing.
The Third Vulnerability: Sleep
The newborn then introduces another variable.
Repeated nighttime waking can transform ordinary postpartum fatigue into substantial sleep deprivation. In a woman biologically susceptible to mood instability, particularly one vulnerable to bipolar-spectrum illness, sleep loss may itself become a psychiatric trigger.
The direction of causation can then reverse.
Initially:
baby wakes
↓
mother cannot sleep
but later:
mother becomes physiologically and psychologically overstimulated
↓
mother cannot sleep even when the baby sleeps.
At this point sleep disturbance is no longer simply an inconvenience imposed by infant care. It has potentially become part of the developing illness.
Sleep deprivation also increases physiological stress and can influence endocrine, immune, inflammatory, and metabolic processes.
The cycle therefore begins to reinforce itself.
The Fourth Vulnerability: Stress
This is where Hoffer's original thinking becomes relevant again.
A mother caring for a difficult newborn while severely sleep deprived may experience sustained physiological stress. Stress activates catecholamine systems, including adrenaline and noradrenaline.
Hoffer and Osmond proposed that in susceptible individuals abnormal oxidation of adrenaline could produce excessive quantities or inadequate clearance of adrenochrome and related aminochromes, contributing to disturbances of perception and thought.
That particular mechanism remains unproven.
It should therefore be represented separately from the better-established components of the model:
sleep loss / stress
↓
increased physiological stress response
↓
catecholamine activity
is well established.
The additional sequence:
catecholamines
↓
pathological adrenochrome/aminochrome accumulation
↓
psychiatric illness
remains the Hoffer hypothesis.
Nevertheless, postpartum physiology provides an interesting environment in which such a hypothesis could now be investigated experimentally rather than merely inferred from symptoms.
Stress Also Returns Us to Tryptophan
Modern research supplies another pathway that Hoffer could not fully have appreciated.
Stress, immune activation, and inflammation can influence the kynurenine pathway.
Thus the same physiological stress that increases catecholamine activity may simultaneously alter the disposition of tryptophan:
stress + inflammatory signaling
↓
altered tryptophan metabolism
↓
kynurenine pathway
↓
changes in neuroactive metabolites and potentially the availability of tryptophan for other purposes.
The proposed model therefore contains two biochemical responses to stress.
One has substantial modern evidence:
stress/inflammation → altered kynurenine metabolism.
The other remains Hoffer's hypothesis:
stress/catecholamines → pathological aminochrome metabolism.
These mechanisms need not be competitors. If Hoffer's pathway exists clinically, both could theoretically operate simultaneously in a susceptible individual.
Lactation Adds Another Nutritional Demand
Breastfeeding prevents the nutritional story from ending with childbirth.
The recommended maternal intake of vitamin B3 remains higher during lactation than in the ordinary nonpregnant state. Vitamin B3 compounds are transferred into breast milk, and experimental evidence now demonstrates that increasing maternal nicotinamide intake can markedly increase B3 concentrations in milk.
The mother therefore moves from supporting the fetus through the placenta to supporting the infant through lactation.
If maternal nutritional status is already marginal, this continuing demand could theoretically reduce her physiological reserve further.
Again, this is not an argument against breastfeeding.
For adequately nourished women, normal lactation is a physiological process for which the human body is adapted.
The hypothesis concerns the possibility that lactation may reveal or intensify an existing nutritional insufficiency in a susceptible woman, particularly when combined with poor intake, stress, and sleep deprivation.
The Infant May Enter the Feedback Loop
The most speculative component concerns the infant.
If marginal maternal B3 status produces lower breast-milk B3, the exclusively breastfed infant may receive less preformed B3. Because young infants depend substantially upon preformed niacin rather than being assumed to derive adult quantities from tryptophan, this relationship deserves investigation.
What remains unknown is whether marginal infant B3 status influences crying, irritability, or sleep.
There is currently insufficient evidence to say that it does.
But suppose future research demonstrated such an association.
The nutritional and psychiatric systems would then become linked through infant behavior:
marginal maternal nutrition
↓
lower breast-milk nutrient availability
↓
marginal infant nutritional status
↓
infant irritability / poor sleep
↓
more crying and nighttime waking
↓
maternal sleep deprivation
↓
increased maternal stress
and the cycle returns to the mother.
This is the proposed mother-infant metabolic feedback loop.
The Cycle Does Not Require a Single Starting Point
An important feature of this hypothesis is that the cycle need not always begin with nutrition.
In one woman, the initiating event might be inadequate dietary intake.
In another, unusually difficult labor or medical complications could produce the initial physiological stress.
In another, an infant who wakes exceptionally frequently for reasons completely unrelated to nutrition could initiate severe maternal sleep deprivation.
In another, preexisting susceptibility to bipolar illness might make relatively modest sleep loss sufficient to initiate mania.
In still another, inflammatory or hormonal sensitivity might dominate.
Once the cycle begins, however, the different processes could theoretically reinforce one another.
For example:
infant wakes repeatedly
↓
mother sleeps poorly
↓
stress increases
↓
appetite deteriorates
↓
diet becomes irregular
↓
nutrient intake declines
↓
metabolic reserve decreases
↓
sleep and mood deteriorate further.
This is important because complex biological disorders frequently do not have a single cause.
A feedback loop can become clinically important even when the event that originally started it is no longer the dominant problem.
A Unified Model
The complete hypothesis can therefore be represented as follows:
PREGNANCY
high pregnancy hormones
+
enhanced tryptophan-niacin metabolism
+
increased nutritional requirements
↓
CHILDBIRTH
rapid hormonal withdrawal
+
physical stress and recovery
+
change in tryptophan-niacin metabolism
↓
EARLY POSTPARTUM
lactation
+
nutritional demands
+
newborn care
+
fragmented sleep
↓
IN A SUSCEPTIBLE WOMAN
marginal B3/tryptophan availability
and/or
abnormal hormonal sensitivity
and/or
inflammatory/metabolic vulnerability
and/or
bipolar/psychiatric susceptibility
↓
SLEEP LOSS + STRESS
↓
altered catecholamine activity
+
altered tryptophan/kynurenine metabolism
↓
mood disturbance / anxiety / insomnia
↓
poorer sleep + poorer nutrition + greater stress
↓
further physiological disturbance
↓
potentially severe postpartum psychiatric illness
A possible secondary loop would run alongside it:
maternal nutritional status
↓
breast-milk B3
↓
infant B3 status
↓
infant irritability or poor sleep (?)
↓
maternal sleep deprivation and stress
The question mark is essential. That portion remains an untested proposition.
Where Hoffer Fits
This model is not simply Hoffer's adrenochrome theory applied to postpartum depression.
Modern research has changed the question considerably.
Hoffer's contribution is the broader proposition that nutritional status, individual biochemical requirements, stress, and abnormal metabolism might interact in producing psychiatric symptoms.
His specific claim that pathological adrenochrome metabolism causes schizophrenia remains controversial and unestablished.
Yet several observations unknown or poorly understood during Hoffer's early work now make the postpartum period particularly interesting:
pregnancy substantially alters tryptophan-niacin metabolism;
that metabolic state changes following childbirth;
low early-postpartum tryptophan has been associated with postpartum depression;
stress and inflammation influence kynurenine metabolism;
sleep deprivation is associated with postpartum psychiatric vulnerability;
lactation maintains increased maternal nutritional requirements;
maternal B3 intake can substantially alter B3 concentrations in breast milk;
and the infant's behavior directly influences maternal sleep and stress.
None of these findings proves Hoffer correct.
Together, however, they suggest that his emphasis upon biochemical individuality and nutritional-metabolic vulnerability may deserve a more sophisticated modern test than simply asking whether a fixed dose of niacin improves a heterogeneous group of psychiatric patients.
A Hypothesis, Not Yet a Treatment
The distinction between hypothesis and treatment is especially important.
It would be premature to conclude from this model that postpartum women should receive pharmacological doses of niacin or large quantities of tryptophan. Increasing the amount of a metabolic precursor does not guarantee that the body will direct it into the desired pathway. Tryptophan, for example, can produce several different kynurenine metabolites, some with very different neurological properties.
The appropriate next step is therefore not indiscriminate supplementation.
It is to determine whether the proposed metabolic pattern actually exists.
If women who develop postpartum psychiatric illness consistently demonstrate abnormalities involving tryptophan, kynurenine metabolites, vitamin B3 status, NAD-related metabolism, sleep, stress, or breast-milk B3 before or during the onset of illness, the hypothesis would become considerably stronger.
If these predicted relationships fail to appear, important portions of the hypothesis should be rejected.
That makes the proposal scientifically useful: it generates predictions capable of being tested.
Before designing such an experiment, however, it is necessary to separate carefully what has already been established from what remains conjecture. The strength of the proposed model depends upon maintaining that distinction.
Part 7. Reconsidering Hoffer: Does the Postpartum Period Fit His Hypothesis?
Having examined pregnancy, childbirth, tryptophan metabolism, vitamin B3, lactation, sleep, and the mother-infant relationship separately, it is useful to return to Abram Hoffer's original hypothesis.
Hoffer did not develop his adrenochrome theory to explain postpartum illness. His principal concern was schizophrenia. It would therefore be historically inaccurate to claim that Hoffer demonstrated that postpartum depression or postpartum psychosis is caused by abnormal adrenochrome metabolism.
Nevertheless, the postpartum period presents an intriguing test of his broader hypothesis because several of the conditions Hoffer believed important appear together with unusual intensity following childbirth.
Hoffer emphasized stress.
Childbirth and the weeks following it can constitute a period of considerable physiological stress. Labor, physical recovery, rapid hormonal changes, lactation, interrupted eating, anxiety, and repeated sleep disruption can occur simultaneously. Modern reviews of postpartum psychosis likewise investigate childbirth-related biological stress, hormonal sensitivity, immune changes, circadian disruption, and sleep loss as possible contributors to illness. The precise mechanism remains uncertain.
Hoffer emphasized adrenaline and the catecholamine response to stress.
Stress activates the body's catecholamine systems. Hoffer's theory proposed that this ordinary physiological response could become pathological in a susceptible person—not because adrenaline itself was abnormal, but because of what happened to it afterward.
Hoffer emphasized oxidation of adrenaline.
Adrenaline can undergo oxidation to form adrenochrome and related aminochromes. Hoffer proposed that excessive production, abnormal metabolism, or inadequate detoxification of these oxidation products could disturb brain function.
And, at the severe end of postpartum psychiatric illness, there is psychosis.
Postpartum psychosis can include hallucinations, delusions, confusion, mania, severe depression, and rapidly changing mental states. It commonly begins within days or weeks of childbirth. Modern evidence indicates that most cases are more closely associated with bipolar-spectrum illness than with schizophrenia, but the biological mechanism by which childbirth precipitates psychosis in a susceptible woman remains incompletely understood.
The correspondence is therefore difficult to ignore:
CHILDBIRTH
↓
major physiological transition
NEWBORN CARE
↓
sleep disruption + psychological stress
STRESS
↓
increased catecholamine activity
ADRENALINE
↓
oxidation products, including adrenochrome
and, in a susceptible minority,
POSTPARTUM PSYCHIATRIC DISTURBANCE
↓
in severe cases
PSYCHOSIS
The important question is whether these observations are merely parallel events or whether they are biologically connected in something resembling the manner Hoffer proposed.
Hoffer's Stress Model
Hoffer himself increasingly emphasized stress as his theory developed.
In a 1994 paper he described schizophrenia as a special case of severe stress in which he believed excessive adrenaline underwent abnormal auto-oxidation to adrenochrome. He argued more broadly that stress increased adrenaline production and that vitamin B3 and antioxidants might help protect against harmful consequences of excessive catecholamine metabolism.
This is important because Hoffer's mature hypothesis was not simply:
adrenochrome causes schizophrenia.
It was closer to:
stress
↓
increased adrenaline
↓
in a metabolically susceptible individual
excessive or abnormal adrenaline oxidation
↓
adrenochrome and related aminochromes
↓
disturbed neurological function
Vitamin B3 entered this model because Hoffer believed sufficiently large amounts could modify aspects of this biochemical environment, while antioxidants were intended to reduce unwanted oxidation.
Whether that mechanism actually occurs in psychiatric patients remains unproven.
But postpartum psychosis presents an unusually interesting condition in which to test it.
Postpartum Psychosis Has a Clearly Defined Biological Trigger
One unusual feature of postpartum psychosis is that its onset can often be connected to a remarkably precise biological event: childbirth.
Researchers studying the disorder have explicitly noted how unusual this is in psychiatry. With many psychiatric illnesses, identifying the event that initiated an episode is difficult. With postpartum psychosis, the severe disturbance frequently appears within a narrow period following delivery. Modern researchers therefore regard childbirth as a potent biological trigger in susceptible women.
This makes postpartum psychosis particularly valuable for testing biochemical hypotheses.
Something changes around childbirth.
We already know that many things change:
estrogen and progesterone fall dramatically;
immune activity changes;
tryptophan metabolism changes;
pregnancy-enhanced niacin metabolism declines;
sleep becomes fragmented;
circadian rhythms are disrupted;
physical and psychological stress increase;
and
lactation creates continuing nutritional demands.
Current research suggests that postpartum psychosis probably arises from an interaction among several such biological vulnerabilities rather than from one universal cause.
Hoffer's theory could therefore be considered as one candidate pathway within this much larger postpartum transition.
Sleep Loss Strengthens the Comparison
Sleep deprivation may provide an especially important bridge.
Modern research increasingly recognizes an association between sleep disruption and postpartum psychosis. Women with bipolar I disorder who report that sleep loss triggers their mania appear particularly vulnerable to postpartum psychosis. A recent expert review reports that such women were approximately twice as likely to have experienced postpartum psychosis during their lifetime.
An earlier review went so far as to propose that sleep loss might represent a final common pathway through which several postpartum factors precipitate psychosis in susceptible women.
This fits remarkably well with a stress-based model.
A woman may begin with the ordinary sleep interruption associated with caring for a newborn.
She becomes increasingly sleep deprived.
Sleep deprivation increases physiological stress.
Stress increases catecholamine activity.
Anxiety and physiological arousal make sleeping still more difficult.
Eventually the woman may be unable to sleep even when somebody else cares for the infant.
For a biologically susceptible individual, the process may progress toward mania or psychosis.
Modern psychiatry can describe much of this sequence without invoking adrenochrome.
Hoffer's hypothesis asks an additional question:
What is happening chemically to the increased catecholamines during this period of sustained physiological stress?
That is a legitimate experimental question even if Hoffer's proposed answer ultimately proves incorrect.
The Niacin Connection Makes the Postpartum Period More Interesting
If Hoffer's theory involved only stress and adrenochrome, its connection with childbirth might be little more than an interesting analogy.
Vitamin B3 changes that.
As demonstrated earlier, pregnancy itself substantially alters the metabolism of tryptophan toward niacin-related products. During late pregnancy, some niacin metabolites rise approximately two to three times above nonpregnant values. Following delivery, this enhanced metabolic condition moves back toward the nonpregnant state.
At almost exactly the same time, the woman enters the period of greatest vulnerability to postpartum psychosis.
This does not demonstrate that the two events are causally related.
But it creates a striking convergence:
Hoffer proposed that B3 status could influence susceptibility to stress-related psychiatric illness.
Pregnancy substantially changes endogenous niacin metabolism.
That metabolic state changes rapidly after delivery.
Postpartum psychiatric illness appears during that same physiological transition.
Stress and sleep deprivation increase after childbirth.
Severe cases can culminate in psychosis.
This is considerably more interesting than simply noticing that Hoffer treated psychosis with niacin.
There is an actual B3-related metabolic transition occurring around the biological event associated with the psychiatric disorder.
Tryptophan Adds Another Layer
Modern research adds something Hoffer could not fully incorporate into his original theory.
Tryptophan sits at the intersection of several systems potentially relevant to postpartum mental health.
It contributes to:
serotonin;
melatonin;
kynurenine metabolites;
and ultimately
NAD+ synthesis.
Postpartum psychosis research has already identified abnormalities involving tryptophan breakdown, while other research implicates immune and inflammatory changes in the disorder.
Thus a modernized version of the Hoffer question need not depend entirely upon adrenochrome.
It could ask whether postpartum illness involves an interaction among:
B3/NAD metabolism;
tryptophan/kynurenine metabolism;
oxidative stress;
catecholamine metabolism;
hormonal withdrawal;
immune activation;
and
sleep deprivation.
Hoffer may have identified only one portion of a much larger biochemical network.
Where Hoffer's Hypothesis Appears to Fit
We can therefore compare several important features of postpartum psychosis with Hoffer's model.
1. A major physiological stressor is present.
Childbirth and early infant care can impose substantial physical and psychological stress.
2. Sleep disruption is present.
Sleep loss is increasingly recognized as an important trigger of postpartum mania and psychosis in susceptible women.
3. Catecholamine activity responds to stress.
This supplies the adrenaline that Hoffer regarded as the starting material of his proposed pathological pathway.
4. Adrenaline can oxidize to adrenochrome.
The chemical reaction upon which Hoffer based his theory is real. What remains uncertain is whether pathological adrenochrome accumulation occurs in postpartum psychiatric illness.
5. Vitamin B3 metabolism changes substantially around pregnancy and childbirth.
This places one of Hoffer's principal therapeutic nutrients directly within the metabolic transition surrounding the illness.
6. Tryptophan metabolism is altered.
Modern postpartum research has independently implicated abnormalities of tryptophan and kynurenine metabolism.
7. Individual susceptibility is essential.
Most mothers experience childbirth, hormonal withdrawal, sleep interruption, and stress without becoming psychotic. Modern postpartum research therefore requires an underlying vulnerability—precisely the sort of biochemical individuality Hoffer emphasized.
8. The ultimate clinical manifestation can be psychosis.
The severe disorder we are attempting to understand includes hallucinations, delusions, confusion, and profound disturbances of thought and mood.
No single one of these observations establishes Hoffer's theory.
Their convergence, however, makes the theory unusually testable in the postpartum setting.
The Missing Evidence
There remains one enormous gap.
We have not demonstrated:
postpartum stress
↓
excessive adrenaline oxidation
↓
pathologically elevated adrenochrome in the nervous system
↓
postpartum psychosis.
Without evidence for those intermediate steps, it would be incorrect to claim that Hoffer has explained postpartum psychosis.
Indeed, current evidence points strongly toward postpartum psychosis being a complex disorder involving bipolar susceptibility, reproductive-hormone sensitivity, circadian disruption, immune changes, genetics, and other factors.
The question is therefore not whether these explanations should be replaced by Hoffer's.
The better question is whether catecholamine oxidation and B3/NAD metabolism should be added to the variables being investigated.
A Theory Worth Testing
This distinction ultimately provides the strongest argument for revisiting Hoffer.
We do not need to accept his theory in advance.
Instead, we can ask whether it makes predictions.
If Hoffer's broader biochemical reasoning has relevance to postpartum psychosis, women developing the disorder might demonstrate measurable differences in some combination of:
catecholamine metabolism;
oxidative stress;
adrenaline oxidation products;
B3 and nicotinamide metabolites;
NAD-related metabolism;
tryptophan and kynurenine metabolites;
inflammatory markers;
and
sleep and circadian disruption.
These measurements could begin during late pregnancy, before illness appears, and continue through the weeks following childbirth.
That is important because it could help distinguish cause from consequence.
If abnormalities appear before psychiatric symptoms, they become candidates for contributing to the illness.
If they appear only after psychosis develops, they may instead be consequences of severe stress and illness.
And if no meaningful differences appear at all, the relevant portion of Hoffer's hypothesis would be weakened.
More than seventy years after Hoffer and Osmond first proposed the adrenochrome hypothesis, modern biochemical methods make such questions far easier to investigate than they were in the 1950s.
The postpartum period may be an especially revealing place to do so.
It combines a precisely timed biological transition, profound hormonal change, altered tryptophan and niacin metabolism, sleep disruption, physiological stress, catecholamine activation, individual susceptibility, and—in its most severe manifestation—psychosis.
That does not prove Hoffer was right.
But it does mean that the postpartum state appears to satisfy a surprising number of the conditions his hypothesis would predict should matter. Rather than treating that correspondence as evidence of causation, it may be more productive to regard it as a reason to subject an old and controversial hypothesis to a new and much more rigorous test.
Testing Vitamin B3 Supplementation
Alongside the observational study, researchers could directly test vitamin B3 supplementation during the postpartum period. There is no need to establish the entire adrenochrome mechanism before asking whether additional B3 has a measurable effect.
Indeed, several observations developed in this paper provide a reasonable basis for such an experiment. Vitamin B3 is an essential nutrient. Maternal requirements increase during pregnancy and remain elevated during lactation. Pregnancy substantially alters tryptophan-to-niacin metabolism, and that enhanced metabolic state changes following childbirth. Maternal B3 intake can also substantially alter the concentration of B3 compounds in breast milk.
A controlled trial could therefore compare postpartum women receiving standard nutritional care with women receiving additional vitamin B3. Researchers could follow maternal mood, sleep, tryptophan and kynurenine metabolism, B3 metabolites, NAD-related metabolism, oxidative-stress markers, catecholamine metabolism, and breast-milk B3.
Different doses could also be investigated. Moderate supplemental doses could establish whether improving B3 availability produces measurable biochemical or clinical effects. If the results suggested a dose-response relationship, subsequent medically supervised studies could examine progressively larger amounts, including doses approaching the pharmacological range employed by Hoffer.
This would provide a direct test of one of the central questions raised by this paper:
Does increasing vitamin B3 availability during the postpartum metabolic transition reduce the incidence or severity of postpartum psychiatric symptoms in susceptible women?
The experiment need not depend upon proving beforehand exactly why B3 might work. If supplementation produced no meaningful difference, that would weaken this portion of the hypothesis. If it produced a reproducible benefit, investigators could then determine whether the effect resulted from improved NAD+ availability, changes in tryptophan metabolism, oxidative protection, altered catecholamine metabolism, correction of marginal nutritional status, or another mechanism.
A later study could similarly investigate tryptophan, either separately or in combination with B3. This could be especially informative because additional preformed B3 might theoretically reduce the body's dependence upon tryptophan as a source of niacin equivalents, while additional dietary tryptophan would increase the available substrate for several competing pathways.
Ultimately, if preliminary studies were favorable, a carefully monitored clinical trial of something closer to Hoffer's high-dose B3 approach would provide the most direct test of whether his therapeutic observations have relevance to postpartum psychiatric illness.
The important distinction is therefore not between supplementation and no supplementation. It is between ordinary nutritional supplementation, experimental higher-dose supplementation, and Hoffer-style pharmacological dosing. Each can be investigated at an appropriate stage and each answers a somewhat different question.
No comments:
Post a Comment